ENST00000505066.5:c.-43+1227G>C
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The ENST00000505066.5(DDR1):c.-43+1227G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.28 in 152,066 control chromosomes in the GnomAD database, including 6,843 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.28 ( 6843 hom., cov: 32)
Consequence
DDR1
ENST00000505066.5 intron
ENST00000505066.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.307
Publications
15 publications found
Genes affected
DDR1 (HGNC:2730): (discoidin domain receptor tyrosine kinase 1) Receptor tyrosine kinases play a key role in the communication of cells with their microenvironment. These kinases are involved in the regulation of cell growth, differentiation and metabolism. The protein encoded by this gene belongs to a subfamily of tyrosine kinase receptors with homology to Dictyostelium discoideum protein discoidin I in their extracellular domain, and that are activated by various types of collagen. Expression of this protein is restricted to epithelial cells, particularly in the kidney, lung, gastrointestinal tract, and brain. In addition, it has been shown to be significantly overexpressed in several human tumors. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Feb 2011]
DDR1 Gene-Disease associations (from GenCC):
- chondrodysplasiaInheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.358 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|
Ensembl
Frequencies
GnomAD3 genomes AF: 0.280 AC: 42506AN: 151948Hom.: 6845 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
42506
AN:
151948
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.280 AC: 42515AN: 152066Hom.: 6843 Cov.: 32 AF XY: 0.281 AC XY: 20889AN XY: 74328 show subpopulations
GnomAD4 genome
AF:
AC:
42515
AN:
152066
Hom.:
Cov.:
32
AF XY:
AC XY:
20889
AN XY:
74328
show subpopulations
African (AFR)
AF:
AC:
5123
AN:
41472
American (AMR)
AF:
AC:
3741
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
AC:
1358
AN:
3470
East Asian (EAS)
AF:
AC:
1327
AN:
5170
South Asian (SAS)
AF:
AC:
1274
AN:
4818
European-Finnish (FIN)
AF:
AC:
4159
AN:
10570
Middle Eastern (MID)
AF:
AC:
105
AN:
292
European-Non Finnish (NFE)
AF:
AC:
24564
AN:
67958
Other (OTH)
AF:
AC:
582
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1517
3033
4550
6066
7583
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
442
884
1326
1768
2210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.